🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
This randomized phase III trial compares ixazomib citrate, lenalidomide, de...
Status
Terminated
Location
Anchorage Associates in Radiation Medicine
Start Date
2016-11-29
Trial ID
NCT02516423
Treatments Being Tested
The primary purpose of this study is to determine the overall response rate...
Status
Withdrawn
Location
CEHON Centro de Hematologia e Oncologia da Bahia
Start Date
2019-09-30
Trial ID
NCT03608501
Treatments Being Tested
The purpose of this study is to see what effects, good and/or bad, the comb...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2016-02
Trial ID
NCT02697383
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Withdrawn
Location
University of Mississippi Medical Center
Start Date
2020-10-31
Trial ID
NCT03888534
Treatments Being Tested
This is an open label, dose escalation, phase I study of the combination of...
Status
Withdrawn
Location
Dartmouth-Hitchcock Medical Center
Start Date
2016-08
Trial ID
NCT03422874
Treatments Being Tested
This protocol is a randomized, open-label, national, multicenter trial stud...
Status
Completed
Location
Complejo Hospitalario Universitario de Santiago
Start Date
2014-11
Trial ID
NCT02406144
Treatments Being Tested
This study aims to evaluate the efficacy of BTK inhibitor Zanubrutinib comb...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2020-06-01
Trial ID
NCT04463953
Treatments Being Tested
Multiple myeloma (MM) is the second most common hematologic malignancy with...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10-02
Trial ID
NCT06050512
Treatments Being Tested
The purpose of this study is to evaluate the tolerability, safety, pharmaco...
Status
Terminated
Location
Multiple Locations
Start Date
2012-06-05
Trial ID
NCT04272775
Treatments Being Tested